SCHEMBL13699310

SCHEMBL13699310

CCOCc1ccc2nn[nH]c2c1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 1/20 0.32
CTNNB1 P35222 1/20 0.32
P2RX7 Q99572 1/20 0.31
NAAA Q02083 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699076 0.83 CA1 (0.33)
SCHEMBL318089 0.81 KIF11 (0.41)
SCHEMBL14208120 0.78 CNR1 (0.39) NISCH
SCHEMBL18671255 0.77 CYP3A4 (0.46)
SCHEMBL3958686 0.75 TUBB4A (0.45)
SCHEMBL10102949 0.75 SMN1; SMN2 (0.45)
SCHEMBL18986083 0.74 S1PR1 (0.47)
SCHEMBL24214987 0.74 RAD52 (0.30)
SCHEMBL10640127 0.74 CBFB (0.41)
SCHEMBL12686295 0.74 GAA (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589067-B2 6, 11-bridged tricyclic macrolides ENANTA PHARMACEUTICALS, INC. (US) 2009-09-15 US disclosed
WO-2007044927-A2 6, 11-BRIDGED TRICYCLIC MACROLIDES ENANTA PHARMACEUTICALS, INC. (US) 2007-04-19 WO disclosed